Flagship Harbor Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $949K | Buy |
10,490
+930
| +10% | +$77.9K | 0.04% | 359 |
|
|
2026
Q1 | $766K | Sell |
9,560
-46
| -0.5% | -$3.79K | 0.03% | 371 |
|
|
2025
Q4 | $819K | Sell |
9,606
-973
| -9% | -$79.9K | 0.04% | 338 |
|
|
2025
Q3 | $823K | Sell |
10,579
-427
| -4% | -$33.4K | 0.04% | 363 |
|
|
2025
Q2 | $861K | Buy |
11,006
+100
| +0.9% | +$7.46K | 0.04% | 336 |
|
|
2025
Q1 | $790K | Sell |
10,906
-307
| -3% | -$22K | 0.04% | 326 |
|
|
2024
Q4 | $830K | Sell |
11,213
-1,932
| -15% | -$135K | 0.04% | 313 |
|
|
2024
Q3 | $867K | Buy |
13,145
+1,178
| +10% | +$85.6K | 0.05% | 293 |
|
|
2024
Q2 | $1.11M | Buy |
11,967
+490
| +4% | +$43.4K | 0.07% | 252 |
|
|
2024
Q1 | $1.1M | Buy |
11,477
+12
| +0.1% | +$1.01K | 0.07% | 236 |
|
|
2023
Q4 | $874K | Buy |
11,465
+1,199
| +12% | +$83.4K | 0.06% | 253 |
|
|
2023
Q3 | $711K | Buy |
10,266
+907
| +10% | +$72.9K | 0.06% | 257 |
|
|
2023
Q2 | $883K | Sell |
9,359
-159
| -2% | -$13.8K | 0.07% | 235 |
|
|
2023
Q1 | $787K | Buy |
9,518
+331
| +4% | +$26K | 0.07% | 256 |
|
|
2022
Q4 | $685K | Buy |
9,187
+1,355
| +17% | +$104K | 0.07% | 268 |
|
|
2022
Q3 | $647K | Buy |
7,832
+335
| +4% | +$32.2K | 0.08% | 254 |
|
|
2022
Q2 | $713K | Sell |
7,497
-147
| -2% | -$15.2K | 0.08% | 259 |
|
|
2022
Q1 | $900K | Sell |
7,644
-90
| -1% | -$10.1K | 0.09% | 237 |
|
|
2021
Q4 | $1M | Sell |
7,734
-218
| -3% | -$25.4K | 0.09% | 233 |
|
|
2021
Q3 | $824K | Hold |
7,952
| – | – | 0.09% | 247 |
|
|
2021
Q2 | $824K | Sell |
7,952
-704
| -8% | -$66.4K | 0.09% | 248 |
|
|
2021
Q1 | $724K | Buy |
8,656
+471
| +6% | +$39.8K | 0.08% | 256 |
|
|
2020
Q4 | $747K | Sell |
8,185
-71
| -0.9% | -$5.89K | 0.09% | 225 |
|
|
2020
Q3 | $658K | Buy |
8,256
+921
| +13% | +$71.9K | 0.09% | 216 |
|
|
2020
Q2 | $506K | Buy |
7,335
+717
| +11% | +$51K | 0.07% | 254 |
|
|
2020
Q1 | $416K | Buy |
6,618
+1,758
| +36% | +$127K | 0.08% | 231 |
|
|
2019
Q4 | $378K | Sell |
4,860
-195
| -4% | -$15.2K | 0.07% | 289 |
|
|
2019
Q3 | $370K | Sell |
5,055
-552
| -10% | -$38.8K | 0.07% | 272 |
|
|
2019
Q2 | $345K | Buy |
5,607
+444
| +9% | +$26.8K | 0.07% | 276 |
|
|
2019
Q1 | $329K | Buy |
5,163
+48
| +0.9% | +$2.74K | 0.07% | 288 |
|
|
2018
Q4 | $261K | Sell |
5,115
-54
| -1% | -$2.73K | 0.06% | 294 |
|
|
2018
Q3 | $294K | Buy |
5,169
+15
| +0.3% | +$734 | 0.05% | 323 |
|
|
2018
Q2 | $250K | Sell |
5,154
-45
| -0.9% | -$2.1K | 0.05% | 338 |
|
|
2018
Q1 | $234K | Sell |
5,199
-1,125
| -18% | -$48.9K | 0.07% | 301 |
|
|
2017
Q4 | $252K | Buy |
+6,324
| New | +$232K | 0.07% | 288 |
|
Other funds holding EW
Flagship Harbor Advisors's EW Position: Q2 2026 in Review
Flagship Harbor Advisors increased its Edwards Lifesciences (EW) stake by 9.7% in Q2 2026, buying an estimated $77.9K and bringing the position to 10,490 shares worth $949K. The position accounts for 0.04% of the portfolio, ranked #359.
Flagship Harbor Advisors first reported a position in EW in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.11M in Q2 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Flagship Harbor Advisors held 10,490 shares of Edwards Lifesciences worth $949K as of Q2 2026.
- Flagship Harbor Advisors bought 930 Edwards Lifesciences shares in Q2 2026, an estimated $77.9K.
- Edwards Lifesciences made up 0.04% of Flagship Harbor Advisors's portfolio in Q2 2026, its #359 holding.
- Flagship Harbor Advisors first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 35 quarters since.
- Flagship Harbor Advisors's Edwards Lifesciences position peaked at $1.11M in Q2 2024.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.